ProfileGDS4718 / 227285_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 29% 35% 65% 37% 35% 47% 34% 34% 34% 33% 36% 39% 34% 42% 32% 29% 39% 40% 28% 43% 31% 30% 36% 40% 33% 30% 34% 31% 38% 38% 30% 46% 34% 35% 33% 51% 36% 36% 38% 79% 33% 37% 46% 34% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.5228229
GSM549102patient 115, normal, homogenized [OPG study]4.7624135
GSM549104patient 119, normal, homogenized [OPG study]6.5400765
GSM549108patient 138, normal, homogenized [OPG study]4.8804337
GSM549119patient 077, normal, homogenized [OPG study]4.784535
GSM549133patient 032, cancer, homogenized [OPG study]5.2910947
GSM549139patient 042, cancer, homogenized [OPG study]4.7132634
GSM549099patient 107, normal, homogenized [OPG study]4.7475734
GSM549109patient 139, normal, homogenized [OPG study]4.7561934
GSM549110patient 046, normal, homogenized [OPG study]4.6656833
GSM549114patient 063, normal, homogenized [OPG study]4.7594236
GSM549122patient 082, normal, homogenized [OPG study]4.9571339
GSM549134patient 033, cancer, homogenized [OPG study]4.6923934
GSM549136patient 036, cancer, homogenized [OPG study]5.0351842
GSM549140patient 044, cancer, homogenized [OPG study]4.5674732
GSM549111patient 047, normal, homogenized [OPG study]4.4912529
GSM549113patient 057, normal, homogenized [OPG study]4.8830939
GSM549132patient 031, cancer, homogenized [OPG study]4.962140
GSM549137patient 038, cancer, homogenized [OPG study]4.447628
GSM549142patient 047, cancer, homogenized [OPG study]5.2740643
GSM549100patient 110, normal, homogenized [OPG study]4.612731
GSM549107patient 135, normal, homogenized [OPG study]4.5051630
GSM549115patient 068, normal, homogenized [OPG study]4.7349136
GSM549116patient 072, normal, homogenized [OPG study]4.966140
GSM549120patient 078, normal, homogenized [OPG study]4.670933
GSM549131patient 030, cancer, homogenized [OPG study]4.493930
GSM549118patient 074, normal, homogenized [OPG study]4.7166234
GSM549129patient 027, cancer, homogenized [OPG study]4.5919131
GSM549123patient 088, normal, homogenized [OPG study]4.8578538
GSM549124patient 006, cancer, homogenized [OPG study]4.9398838
GSM549126patient 015, cancer, homogenized [OPG study]4.515930
GSM549128patient 025, cancer, homogenized [OPG study]5.3017546
GSM549103patient 117, normal, homogenized [OPG study]4.782934
GSM549117patient 073, normal, homogenized [OPG study]4.7437435
GSM549138patient 041, cancer, homogenized [OPG study]4.6607133
GSM549141patient 045, cancer, homogenized [OPG study]5.5087451
GSM549130patient 028, cancer, homogenized [OPG study]4.8069736
GSM549101patient 111, normal, homogenized [OPG study]4.8513136
GSM549105patient 128, normal, homogenized [OPG study]4.9223538
GSM549106patient 134, normal, homogenized [OPG study]7.923479
GSM549112patient 048, normal, homogenized [OPG study]4.6683733
GSM549125patient 011, cancer, homogenized [OPG study]4.8744437
GSM549127patient 024, cancer, homogenized [OPG study]5.3156446
GSM549135patient 035, cancer, homogenized [OPG study]4.6748734